Sansure Biotech Inc.SSE: 688289

Report for Q1 2026

Apr 30, 2026 · Issued by Sansure Biotech Inc. via Shanghai Stock Exchange

Filed with SSE · Apr 30, 2026

On 6ix: 6ix.com/news/report-for-q1-2026-620

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Sansure Biotech Inc. on 6ix

Earlier from Sansure Biotech

Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Relevant ProductsApr 29
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026Apr 24
Notice on Convening the 2nd Extraordinary General Meeting in 2026Apr 8
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Apr 1
Announcement on Joint Investment with a Related Party in Huasi Wuwei Technology (Shenzhen) Co., Ltd.Mar 16

Later from Sansure Biotech

All Sansure Biotech news releases

Follow Sansure Biotech into a list and get an email when it puts out news.

Follow Sansure Biotech